Related Experiment Video
Updated: Aug 12, 2026
07:56
Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
[Evidence-based medicine: labor induction with prostaglandins]
1Frauenklinik für Gynäkologie und Geburtshilfe, Universitätsklinikum der Rheinisch-Wesffälischen Technischen Hochschule, Aachen.
Zeitschrift Fur Geburtshilfe Und Neonatologie
|December 28, 1999
Summary
Prostaglandins (PG) effectively ripen the cervix for labor induction, with PGE2 reducing cesarean rates. However, more research is needed due to limited scientific data on PG efficacy.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Pharmacology
Context:
- 10-15% of births in Germany are induced using prostaglandins (PG).
- Limited scientific data exists on the efficacy of PG for cervical ripening.
- Evidence for PG efficacy in labor induction needs comprehensive review.
Purpose:
- To survey the scientific evidence for the efficacy of prostaglandins (PG) in promoting cervical ripening.
- To compare the effectiveness of local PGE2 and PGE1 with placebo, conservative management, and oxytocin.
- To evaluate the impact of PG on labor induction outcomes and fetal well-being.
Summary:
- PGE2 is more effective than placebo or conservative management for cervical ripening, reducing cesarean and instrumental delivery rates without affecting fetal outcomes.
- PGE2 surpasses oxytocin in effectiveness for unripe cervices, shortening induction-delivery intervals.
- PGE1 shows promise but may increase uterine hyperstimulation risks.
Impact:
- Provides evidence for the efficacy of PGE2 in labor induction and cervical ripening.
- Highlights the need for more rigorous, standardized research on prostaglandin use in obstetrics.
- Informs clinical discussions with patients regarding labor induction methods and their associated risks and benefits.
Related Concept Videos
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...